Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
Enrolling by invitation · NCT06859099 · Registry updated 2026-09-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic inflammatory demyelinating polyradiculoneuropathy, demyelinating disease, immune system disorder, nervous system disorder, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, polyradiculoneuropathy | Enrolling by invitation | Phase 3 | 2026-09-30 | NCT06859099 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sanofi | 254 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Alabama Neurology Associates- Site Number : 8400019 | Homewood | United States | 3 |
| Honor Health Scottsdale Osborn Medical Center- Site Number : 8400014 | Scottsdale | United States | 2 |
| Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto- Site Number : 0760004 | Ribeirão Preto | Brazil | 1 |
| L2IP - Instituto de Pesquisas Clínicas- Site Number : 0760006 | Brasília | Brazil | 2 |
| Penn Medicine: University of Pennsylvania Health System- Site Number : 8400022 | Philadelphia | United States | 3 |
| PSEG Centro de Pesquisa Clínica- Site Number : 0760009 | São Paulo | Brazil | 3 |
| University of Kansas Medical Center- Site Number : 8400010 | Kansas City | United States | 3 |